Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Post-Oral Surgery Inflammation
NCT00006070Phase 2Completed
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- Jul 2000
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of etanercept in postoperative pain and acute inflammation (3 arms), sponsored by National Institute of Dental and Craniofacial Research. Primary endpoints: Postoperative Pain at 48 hours and Postoperative Swelling at 48 hours. Started Jul 2000; status: completed.
02
Drugs
etanercept
03
Conditions
postoperative painacute inflammation
Beyond the preview
Go deeper on NCT00006070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006070.